ATYR
aTyr Pharma, Inc. - Common Stock (ATYR)
$36
About aTyr Pharma, Inc. - Common Stock (ATYR)
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.12
52 Week Low
$0.36
Market cap
35.6M
Dividend yield
-
Volume
665
Avg. volume
821,070
P/E ratio
-.58
aTyr Pharma, Inc. - Common Stock News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.12
52 Week Low
$0.36
Market cap
35.6M
Dividend yield
-
Volume
665
Avg. volume
821,070
P/E ratio
-.58